Gram-negative Bacteremia Clinical Trial
Official title:
Randomized Trial Assessing the Clinical Impact of Fast Bacteria Identification and Phenotypic Antimicrobial Susceptibility Testing on Patients With Bacteremic Due to Gram-Negative Rods
The FDA-cleared Accelerate Pheno™ System and PhenoTest™ Blood Culture (BC) Kit will be used to assess the workflow impact of fast identification (ID)/ antimicrobial susceptibility testing (AST) in the microbiology lab and in the quality of care in patients with Gram-negative rod (GNR) bacteremia. Blood culture work up will be randomized to one of two arms: the positive blood culture will either undergo fast ID and AST using the Accelerate Pheno™ System and PhenoTest™ BC Kit or processing per the site's standard of care (SOC) procedures.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03218397 -
Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia
|
N/A | |
| Enrolling by invitation |
NCT04055922 -
Comparison of Solid Organ Transplant
|
||
| Recruiting |
NCT04291768 -
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
|
Phase 4 | |
| Not yet recruiting |
NCT06214403 -
Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation
|
Phase 2 | |
| Completed |
NCT05605275 -
CRP and PCT as Predictors of Sepsis Cause
|
||
| Completed |
NCT02599220 -
Clinical Outcomes and Cost of Gram Negative Bacteremia
|
N/A | |
| Recruiting |
NCT06080698 -
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
|
N/A | |
| Recruiting |
NCT06174649 -
Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial
|
N/A | |
| Recruiting |
NCT05893147 -
BALANCE+ Vanguard Phase
|
N/A |